FDA Accepts Astellas’ New Drug Application for Fezolinetant
Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for fezolinetant, an investigational oral,…
Read More...
Read More...
